Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Weiss

Showing results (91-100 of 182) with videos related to

Pageof 19
Sort By:
Frontiers in Cellular and Infection Microbiology|November 22, 2021
A LysR-Type Transcriptional Regulator Controls Multiple Phenotypes in <i>Acinetobacter baumannii</i>Aimee R P Tierney, Chui Yoke Chin, David S Weiss, et al.
The Journal of Experimental Medicine|April 25, 2007
Type I interferon signaling is required for activation of the inflammasome during Francisella infectionThomas Henry, Anna Brotcke, David S Weiss, et al.
Journal of Pharmaceutical Sciences|December 17, 2013
Iontophoresis successfully delivers dexamethasone sodium phosphate to dermis as measured by microdialysisAbhay Joshi, Grazia Stagni, Ann Cleary, et al.
The Journal of Physiology|September 23, 2006
Stoichiometry of a pore mutation that abolishes picrotoxin-mediated antagonism of the GABAA receptorAnna Sedelnikova, Brian E Erkkila, Holly Harris, et al.
Science (New York, N.Y.)|March 29, 2020
Observation of dynamical fermionizationJoshua M Wilson, Neel Malvania, Yuan Le, et al.
Cellular Microbiology|May 29, 2012
Repression of bacterial lipoprotein production by Francisella novicida facilitates evasion of innate immune recognitionCrystal L Jones, Timothy R Sampson, Helder I Nakaya, et al.
The Lancet. Infectious Diseases|April 25, 2021
Widespread cefiderocol heteroresistance in carbapenem-resistant Gram-negative pathogensJacob E Choby, Tugba Ozturk, Sarah W Satola, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2015
Cas9-mediated targeting of viral RNA in eukaryotic cellsAryn A Price, Timothy R Sampson, Hannah K Ratner, et al.
The Lancet. Microbe|May 11, 2022
Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results?Jacob E Choby, Tugba Ozturk, Sarah W Satola, et al.
The Physician and Sportsmedicine|December 26, 2017
ForumRichard T Herrick, Fred B Benjamin, Christine Bratton, et al.
Pageof 19

Showing results (91-100 of 182) with videos related to

Sort By:
Pageof 19
Frontiers in Cellular and Infection Microbiology|November 22, 2021
A LysR-Type Transcriptional Regulator Controls Multiple Phenotypes in <i>Acinetobacter baumannii</i>Aimee R P Tierney, Chui Yoke Chin, David S Weiss, et al.
The Journal of Experimental Medicine|April 25, 2007
Type I interferon signaling is required for activation of the inflammasome during Francisella infectionThomas Henry, Anna Brotcke, David S Weiss, et al.
Journal of Pharmaceutical Sciences|December 17, 2013
Iontophoresis successfully delivers dexamethasone sodium phosphate to dermis as measured by microdialysisAbhay Joshi, Grazia Stagni, Ann Cleary, et al.
The Journal of Physiology|September 23, 2006
Stoichiometry of a pore mutation that abolishes picrotoxin-mediated antagonism of the GABAA receptorAnna Sedelnikova, Brian E Erkkila, Holly Harris, et al.
Science (New York, N.Y.)|March 29, 2020
Observation of dynamical fermionizationJoshua M Wilson, Neel Malvania, Yuan Le, et al.
Cellular Microbiology|May 29, 2012
Repression of bacterial lipoprotein production by Francisella novicida facilitates evasion of innate immune recognitionCrystal L Jones, Timothy R Sampson, Helder I Nakaya, et al.
The Lancet. Infectious Diseases|April 25, 2021
Widespread cefiderocol heteroresistance in carbapenem-resistant Gram-negative pathogensJacob E Choby, Tugba Ozturk, Sarah W Satola, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2015
Cas9-mediated targeting of viral RNA in eukaryotic cellsAryn A Price, Timothy R Sampson, Hannah K Ratner, et al.
The Lancet. Microbe|May 11, 2022
Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results?Jacob E Choby, Tugba Ozturk, Sarah W Satola, et al.
The Physician and Sportsmedicine|December 26, 2017
ForumRichard T Herrick, Fred B Benjamin, Christine Bratton, et al.
Pageof 19